|
C17ORF65 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.18120000236877E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.09289999999674E-05 |
| Normal-vs-Stage2 |
8.535700E-03 |
| Normal-vs-Stage3 |
6.29329999999317E-05 |
| Normal-vs-Stage4 |
2.48059999999883E-05 |
| Stage1-vs-Stage2 |
6.109000E-01 |
| Stage1-vs-Stage3 |
3.991200E-01 |
| Stage1-vs-Stage4 |
7.372200E-02 |
| Stage2-vs-Stage3 |
9.744000E-01 |
| Stage2-vs-Stage4 |
4.007200E-01 |
| Stage3-vs-Stage4 |
2.858400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.7583000001582E-07 |
| Normal-vs-AfricanAmerican |
4.21150000000647E-05 |
| Normal-vs-Asian |
7.196200E-03 |
| Caucasian-vs-AfricanAmerican |
1.585990E-01 |
| Caucasian-vs-Asian |
3.380400E-02 |
| AfricanAmerican-vs-Asian |
1.083770E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.39749999999739E-05 |
| Normal-vs-Female |
4.40570002702145E-09 |
| Male-vs-Female |
5.719100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.933700E-02 |
| Normal-vs-Age(41-60Yrs) |
4.82699999970748E-08 |
| Normal-vs-Age(61-80Yrs) |
6.17499999999715E-05 |
| Normal-vs-Age(81-100Yrs) |
6.439900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.674600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.814800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.907400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.933820E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.626000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.189200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.87759999951076E-07 |
| Normal-vs-Grade 2 |
4.32679999999852E-05 |
| Normal-vs-Grade 3 |
1.63129999999345E-05 |
| Normal-vs-Grade 4 |
3.81930000000752E-05 |
| Grade 1-vs-Grade 2 |
8.176300E-02 |
| Grade 1-vs-Grade 3 |
7.702400E-02 |
| Grade 1-vs-Grade 4 |
3.251200E-01 |
| Grade 2-vs-Grade 3 |
7.935000E-01 |
| Grade 2-vs-Grade 4 |
1.483410E-01 |
| Grade 3-vs-Grade 4 |
1.895220E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.91880000000233E-05 |
| Normal-vs-ccB subtype |
6.36549999999403E-05 |
| ccA subtype-vs-ccB subtype |
6.315600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.16429999980272E-07 |
| Normal-vs-N1 |
3.835700E-04 |
| N0-vs-N1 |
6.434600E-01 |
|
|
